Effect of motion control versus neutral walking footwear on pain associated with lateral tibiofemoral joint osteoarthritis: a comparative effectiveness randomised clinical trial

KL Paterson; KL Bennell; BR Metcalf; PK Campbell; F Mcmanus; KE Lamb; RS Hinman

Journal article

Effect of motion control versus neutral walking footwear on pain associated with lateral tibiofemoral joint osteoarthritis: a comparative effectiveness randomised clinical trial

KL Paterson, KL Bennell, BR Metcalf, PK Campbell, F Mcmanus, KE Lamb, RS Hinman

BMJ Open | Published : 2022

DOI: 10.1136/bmjopen-2022-061627

Download PDF

Abstract

Objectives To determine if motion control walking shoes are superior to neutral walking shoes in reducing knee pain on walking in people with lateral knee osteoarthritis (OA). Design Participant-blinded and assessor-blinded, comparative effectiveness, superiority randomised controlled trial. Setting Melbourne, Australia. Participants People with symptomatic radiographic lateral tibiofemoral OA from the community and our volunteer database. Intervention Participants were randomised to receive either motion control or neutral shoes and advised to wear them >6 hours/day over 6 months. Primary and secondary outcome measures The primary outcome was change in average knee pain on walking over the ..

View full abstract

University of Melbourne Researchers

Kade Paterson Author

Kim Bennell Author

Ben Metcalf Author

Penny Campbell Author

Related Projects (2)

FOOTWEAR FOR SELF-MANAGING KNEE OSTEOARTHRITIS SYMPTOMS: THE FOOTSTEP TRIAL

Self-management of symptoms is an important part of treatment for people with knee osteoarthritis. Footwear influences forces across the kne..

LIFESTYLE MANAGEMENT OF KNEE OSTEOARTHRITIS: CLOSING THE GAPS TO REDUCE DISEASE BURDEN

Arthritis and musculoskeletal conditions are a National Health Priority Area, and more prevalent in Australia than any other, including canc..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

This study was funded by the National Health and Medical Research Council (Project Grant #1124418). KLP is supported by a National Health and Medical Research Council Emerging Leadership Investigator Grant (#1174229). KLB is supported by a National Health and Medical Research Council Leadership Investigator Grant (#1174431). RSH is supported by a National Health and Medical Research Council Senior Research Fellowship (#1154217).